Neurovascular Devices Market Size, Share, Trends, & Industry Analysis Report By Device Type, By Application, By End User, and By Region – Market Forecast, 2025–2034
Description
The global neurovascular intervention devices market size is expected to reach USD 4.22 billion by 2028 according to a new study by Polaris Market Research. The report “Neurovascular Intervention Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Artificial Embolization Devices, Stents, Thrombectomy Devices, Support Devices); By Application (Intracranial Aneurysm, Ischemic Stroke, Arteriovenous Malformation); By Region; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Neurovascular intervention devices are used in the treatment of various neurological conditions such as epilepsy, stroke, and some form of CNS tumors. Neurovascular intervention devices include artificial embolization devices, stents, thrombectomy devices, and other support devices such as microcatheters and an embolic protection system.
Stents in neurology are mainly used to open up narrowed arteries or veins in the nervous system. There are various types of stents that include intracranial stents, stenosis stents, stent-graft, aneurysm coil stents, neck reconstruction stents, and carotid stents, which are widely used in healthcare market driving the growth for neurovascular intervention devices industry.
Thrombectomy devices use technologies such as ultrasound-assisted catheter-directed thrombolysis that aids thrombolytic agents to penetrate and clear the clots. Artificial embolization devices are used in plugging arteriovenous malformations with small platinum coils or glue material to control hemorrhaging caused by aneurysms and arteriovenous malformations.
The increase in neurological disorders, aged population, and increasing demand for non-invasive procedures is expected to boost the global market for neurovascular intervention devices market during the forecast period. Every year nearly 15 million people suffer from stroke and around 5 million deaths worldwide. High blood pressure is responsible for more than 12 million strokes globally.
Several new products have been launched in the global market for neurovascular intervention devices market in the recent period. MicroVention received FDA Approval for the WEB 17 System in January 2021. It is a WEB Aneurysm Embolization System based on microbraid technology. The system consists of a lower profile delivery system along VIA 17 microcatheter and it is used in the treatment of intracranial wide-neck bifurcation aneurysms.
In 2020, Medtronic acquired RIST Neurovascular Inc., which has developed RIST Cath Radial Access Long Sheath (RIST Cath), used in treating various conditions in the coronary, peripheral and neurovascular system. In February 2021, Medtronic has announced the expansion of the restricted site release of RIST Neurovascular, Inc.'s newly acquired radial artery access portfolio, which comprises the Rist Radial Access Selective Catheter and Rist 079 Radial Access Guide Catheter.
Market Participants such as Medtronic Plc, Stryker Corporation, Terumo Corporation (MicroVention, Inc.), Balt Extrusion, Penumbra, Inc., Boston Scientific Corporation, Johnson & Johnson, Silk Road Medical Inc., Abbott Laboratories, Acandis GmbH, and Microport Scientific Corporation are some of the key players operating in the global market for neurovascular intervention devices.
Polaris Market Research has segmented the neurovascular intervention devices market report on the basis of product, application, and region:
Neurovascular Intervention Devices, Product Outlook (Revenue - USD Million, 2016 - 2028)
• Artificial Embolization Devices
o Coils
• Bare Metal Coils
• Coated Coils
o Liquid Embolics
o Flow Diverters
o Flow Disruptor
o Others
• Stents
o Intracranial Stents
• Stenosis Stents
• Aneurysm Coil Stents
o Carotid Stents
• Thrombectomy Devices
o Stent Retrievers
o Aspiration Devices
• Support Devices
Neurovascular Intervention Devices, Application Outlook (Revenue - USD Million, 2016 - 2028)
• Intracranial Aneurysm
• Ischemic Stroke
• Arteriovenous Malformation
• Other Diseases
Neurovascular Intervention Devices, Regional Outlook (Revenue - USD Million, 2016 - 2028)
• North America
o U.S.
o Canada
• Europe
o France
o Germany
o UK
o Italy
o Spain
o Netherlands
o Austria
• Asia Pacific
o China
o India
o Japan
o Malaysia
o South Korea
o Indonesia
• Central & South America
o Mexico
o Brazil
o Argentina
• Middle East & Africa
o UAE
o Saudi Arabia
o Israel
o South Africa
Neurovascular intervention devices are used in the treatment of various neurological conditions such as epilepsy, stroke, and some form of CNS tumors. Neurovascular intervention devices include artificial embolization devices, stents, thrombectomy devices, and other support devices such as microcatheters and an embolic protection system.
Stents in neurology are mainly used to open up narrowed arteries or veins in the nervous system. There are various types of stents that include intracranial stents, stenosis stents, stent-graft, aneurysm coil stents, neck reconstruction stents, and carotid stents, which are widely used in healthcare market driving the growth for neurovascular intervention devices industry.
Thrombectomy devices use technologies such as ultrasound-assisted catheter-directed thrombolysis that aids thrombolytic agents to penetrate and clear the clots. Artificial embolization devices are used in plugging arteriovenous malformations with small platinum coils or glue material to control hemorrhaging caused by aneurysms and arteriovenous malformations.
The increase in neurological disorders, aged population, and increasing demand for non-invasive procedures is expected to boost the global market for neurovascular intervention devices market during the forecast period. Every year nearly 15 million people suffer from stroke and around 5 million deaths worldwide. High blood pressure is responsible for more than 12 million strokes globally.
Several new products have been launched in the global market for neurovascular intervention devices market in the recent period. MicroVention received FDA Approval for the WEB 17 System in January 2021. It is a WEB Aneurysm Embolization System based on microbraid technology. The system consists of a lower profile delivery system along VIA 17 microcatheter and it is used in the treatment of intracranial wide-neck bifurcation aneurysms.
In 2020, Medtronic acquired RIST Neurovascular Inc., which has developed RIST Cath Radial Access Long Sheath (RIST Cath), used in treating various conditions in the coronary, peripheral and neurovascular system. In February 2021, Medtronic has announced the expansion of the restricted site release of RIST Neurovascular, Inc.'s newly acquired radial artery access portfolio, which comprises the Rist Radial Access Selective Catheter and Rist 079 Radial Access Guide Catheter.
Market Participants such as Medtronic Plc, Stryker Corporation, Terumo Corporation (MicroVention, Inc.), Balt Extrusion, Penumbra, Inc., Boston Scientific Corporation, Johnson & Johnson, Silk Road Medical Inc., Abbott Laboratories, Acandis GmbH, and Microport Scientific Corporation are some of the key players operating in the global market for neurovascular intervention devices.
Polaris Market Research has segmented the neurovascular intervention devices market report on the basis of product, application, and region:
Neurovascular Intervention Devices, Product Outlook (Revenue - USD Million, 2016 - 2028)
• Artificial Embolization Devices
o Coils
• Bare Metal Coils
• Coated Coils
o Liquid Embolics
o Flow Diverters
o Flow Disruptor
o Others
• Stents
o Intracranial Stents
• Stenosis Stents
• Aneurysm Coil Stents
o Carotid Stents
• Thrombectomy Devices
o Stent Retrievers
o Aspiration Devices
• Support Devices
Neurovascular Intervention Devices, Application Outlook (Revenue - USD Million, 2016 - 2028)
• Intracranial Aneurysm
• Ischemic Stroke
• Arteriovenous Malformation
• Other Diseases
Neurovascular Intervention Devices, Regional Outlook (Revenue - USD Million, 2016 - 2028)
• North America
o U.S.
o Canada
• Europe
o France
o Germany
o UK
o Italy
o Spain
o Netherlands
o Austria
• Asia Pacific
o China
o India
o Japan
o Malaysia
o South Korea
o Indonesia
• Central & South America
o Mexico
o Brazil
o Argentina
• Middle East & Africa
o UAE
o Saudi Arabia
o Israel
o South Africa
Table of Contents
126 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Neurovascular Devices Market Insights
- 4.1. Neurovascular Devices Market – Market Snapshot
- 4.2. Neurovascular Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Aging Global Population Increasing the Incidence of Neurovascular Disorders
- 4.2.1.2. Growing Demand for Minimally Invasive Neurovascular Procedures
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Costs of Advanced Devices and Limited Availability of Skilled Neurointerventional Specialists
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Neurovascular Devices Market Trends
- 4.6. Value Chain Analysis
- 5. Global Neurovascular Devices Market, by Device Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 5.3. Stenting Systems
- 5.3.1. Global Neurovascular Devices Market, by Stenting Systems, by Region, 2020-2034 (USD Billion)
- 5.4. Embolization Devices
- 5.4.1. Global Neurovascular Devices Market, by Embolization Devices, by Region, 2020-2034 (USD Billion)
- 5.5. Neurothrombectomy Devices
- 5.5.1. Global Neurovascular Devices Market, by Neurothrombectomy Devices, by Region, 2020-2034 (USD Billion)
- 5.6. Support Devices
- 5.6.1. Global Neurovascular Devices Market, by Support Devices, by Region, 2020-2034 (USD Billion)
- 6. Global Neurovascular Devices Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 6.3. Cerebral Aneurysms
- 6.3.1. Global Neurovascular Devices Market, by Cerebral Aneurysms, by Region, 2020-2034 (USD Billion)
- 6.4. Ischemic Stroke
- 6.4.1. Global Neurovascular Devices Market, by Ischemic Stroke, by Region, 2020-2034 (USD Billion)
- 6.5. Other Application
- 6.5.1. Global Neurovascular Devices Market, by Other Application, by Region, 2020-2034 (USD Billion)
- 7. Global Neurovascular Devices Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Global Neurovascular Devices Market, by Hospitals, by Region, 2020-2034 (USD Billion)
- 7.4. Specialty Clinics
- 7.4.1. Global Neurovascular Devices Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
- 7.5. Other End User
- 7.5.1. Global Neurovascular Devices Market, by Other End User, by Region, 2020-2034 (USD Billion)
- 8. Global Neurovascular Devices Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Neurovascular Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
- 8.3. Neurovascular Devices Market – North America
- 8.3.1. North America: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Neurovascular Devices Market – U.S.
- 8.3.4.1. U.S.: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.4.2. U.S.: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.3.4.3. U.S.: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Neurovascular Devices Market – Canada
- 8.3.5.1. Canada: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.3.5.2. Canada: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.3.5.3. Canada: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4. Neurovascular Devices Market – Europe
- 8.4.1. Europe: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Neurovascular Devices Market – UK
- 8.4.4.1. UK: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.4.2. UK: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.4.3. UK: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Neurovascular Devices Market – France
- 8.4.5.1. France: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.5.2. France: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.5.3. France: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Neurovascular Devices Market – Germany
- 8.4.6.1. Germany: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.6.2. Germany: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.6.3. Germany: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Neurovascular Devices Market – Italy
- 8.4.7.1. Italy: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.7.2. Italy: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.7.3. Italy: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Neurovascular Devices Market – Spain
- 8.4.8.1. Spain: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.8.2. Spain: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.8.3. Spain: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Neurovascular Devices Market – Netherlands
- 8.4.9.1. Netherlands: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.9.2. Netherlands: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.9.3. Netherlands: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Neurovascular Devices Market – Russia
- 8.4.10.1. Russia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.10.2. Russia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.10.3. Russia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Neurovascular Devices Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.4.11.2. Rest of Europe: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.11.3. Rest of Europe: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5. Neurovascular Devices Market – Asia Pacific
- 8.5.1. Asia Pacific: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Neurovascular Devices Market – China
- 8.5.4.1. China: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.4.2. China: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.4.3. China: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Neurovascular Devices Market – India
- 8.5.5.1. India: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.5.2. India: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.5.3. India: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Neurovascular Devices Market – Malaysia
- 8.5.6.1. Malaysia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.6.2. Malaysia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.6.3. Malaysia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Neurovascular Devices Market – Japan
- 8.5.7.1. Japan: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.7.2. Japan: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.7.3. Japan: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Neurovascular Devices Market – Indonesia
- 8.5.8.1. Indonesia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.8.2. Indonesia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.8.3. Indonesia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Neurovascular Devices Market – South Korea
- 8.5.9.1. South Korea: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.9.2. South Korea: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.9.3. South Korea: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Neurovascular Devices Market – Australia
- 8.5.10.1. Australia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.10.2. Australia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.10.3. Australia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Neurovascular Devices Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.5.11.2. Rest of Asia Pacific: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.11.3. Rest of Asia Pacific: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6. Neurovascular Devices Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Neurovascular Devices Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.4.2. Saudi Arabia: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.4.3. Saudi Arabia: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Neurovascular Devices Market – UAE
- 8.6.5.1. UAE: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.5.2. UAE: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.5.3. UAE: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Neurovascular Devices Market – Israel
- 8.6.6.1. Israel: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.6.2. Israel: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.6.3. Israel: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Neurovascular Devices Market – South Africa
- 8.6.7.1. South Africa: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.7.2. South Africa: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.7.3. South Africa: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Neurovascular Devices Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.6.8.2. Rest of Middle East & Africa: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.8.3. Rest of Middle East & Africa: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7. Neurovascular Devices Market – Latin America
- 8.7.1. Latin America: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Neurovascular Devices Market – Mexico
- 8.7.4.1. Mexico: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.4.2. Mexico: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.4.3. Mexico: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Neurovascular Devices Market – Brazil
- 8.7.5.1. Brazil: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.5.2. Brazil: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.5.3. Brazil: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Neurovascular Devices Market – Argentina
- 8.7.6.1. Argentina: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.6.2. Argentina: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.6.3. Argentina: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Neurovascular Devices Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Neurovascular Devices Market, by Device Type, 2020-2034 (USD Billion)
- 8.7.7.2. Rest of Latin America: Neurovascular Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.7.3. Rest of Latin America: Neurovascular Devices Market, by End User, 2020-2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Acandis GmbH
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Asahi Intecc Co., Ltd.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Balt Group SAS
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Johnson & Johnson
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Kaneka Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Medtronic plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. MicroPort Scientific Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Penumbra, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. phenox GmbH
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Rapid Medical Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Stryker Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Terumo Corporation
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.